Bevantolol (

INN Inns are generally establishments or buildings where travelers can seek lodging, and usually, food and drink. Inns are typically located in the country or along a highway. Before the advent of motorized transportation, they also provided accomm ...

) was a drug candidate for angina and hypertension that acted as both a

beta blocker Beta blockers, also spelled β-blockers, are a class of medications that are predominantly used to manage abnormal heart rhythms ( arrhythmia), and to protect the heart from a second heart attack after a first heart attack ( secondary prevention ...

and a

calcium channel blocker Calcium channel blockers (CCB), calcium channel antagonists or calcium antagonists are a group of medications that disrupt the movement of calcium () through calcium channels. Calcium channel blockers are used as antihypertensive drugs, i.e., as ...

. It was

discovered Discovery is the act of detecting something new, or something previously unrecognized as meaningful, "portal". In sciences and academic disciplines, discovery is the observation of new phenomena, new actions, or new events and involves providin ...

and developed by Warner-Lambert but in January 1989 the company announced that it had withdrawn the

New Drug Application The Food and Drug Administration's (FDA) New Drug Application (NDA) is the vehicle in the United States through which drug sponsors formally propose that the FDA approve a new pharmaceutical for sale and marketing. Some 30% or less of initial ...

; the company's chairman said: "Who needs the 30th beta blocker?" it wasn't marketed in the US, UK, or Europe and the authors of a Cochrane review could find no product monograph for it.

References

Abandoned drugs Beta blockers Catechol ethers Methoxyphenethylamines O-methylated phenols Phenoxypropanolamines {{cardiovascular-drug-stub